Revenue of the digestives & intestinal remedies market worldwide by country 2022

From the selected regions, the ranking by revenue in the digestives & intestinal remedies segment of the OTC pharmaceuticals market is led by China with 4.5 billion U.S. dollars and is followed by the United States (1.8 billion U.S. dollars). In contrast, the ranking is trailed by Turkey with 8.35 million U.S. dollars, recording a difference of 4.5 billion U.S. dollars to China.

Find other insights concerning similiar markets and segments, such as a ranking by country regarding revenue in the cold & cough remedies segment of the OTC pharmaceuticals market and a ranking by country regarding revenue in the analgesics segment of the OTC pharmaceuticals market.

Revenue of the digestives & intestinal remedies market worldwide by country in 2022 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

The digestives segment comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Citation formats